MCM
EW icon

Moore Capital Management’s Edwards Lifesciences EW Stock Holding History

Moore Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,710
Closed -$430K – 210
2016
Q3 		$430K Buy
10,710
+3,741
+54% +$141K 0.01% 201
2016
Q2 		$232K Buy
+6,969
New +$238K 0.01% 246
2016
Q1 		– Sell
-360,000
Closed -$9.48M – 268
2015
Q4 		$9.48M Sell
360,000
-247,914
-41% -$6.44M 0.29% 93
2015
Q3 		$14.4M Buy
+607,914
New +$14.7M 0.67% 31

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Moore Capital Management's EW Position: Q4 2016 in Review

Moore Capital Management sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 10,710 shares — an estimated $430K sold.

Moore Capital Management first reported a position in EW in Q3 2015 and held it in 4 quarters. The position peaked at $14.4M in Q3 2015. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

  • Moore Capital Management reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
  • Moore Capital Management sold 10,710 Edwards Lifesciences shares in Q4 2016, an estimated $430K.
  • Moore Capital Management first reported a position in Edwards Lifesciences in Q3 2015 and held it in 4 quarters.
  • Moore Capital Management's Edwards Lifesciences position peaked at $14.4M in Q3 2015.
  • 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Moore Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.